Naples Prognostic Score and Prediction of Left Ventricular Ejection Fraction in STEMI Patients.


Journal

Angiology
ISSN: 1940-1574
Titre abrégé: Angiology
Pays: United States
ID NLM: 0203706

Informations de publication

Date de publication:
01 2024
Historique:
medline: 28 11 2023
pubmed: 3 3 2023
entrez: 2 3 2023
Statut: ppublish

Résumé

The Naples score is a new prognostic score developed according to inflammatory and nutritional status and frequently evaluated in cancer patients. The present study aimed to evaluate using the Naples prognostic score (NPS) to predict the development of decreased left ventricular ejection fraction (LVEF) after acute ST-segment elevation myocardial infarction (STEMI). The study has a multicenter and retrospective design and included 2280 patients with STEMI who underwent primary percutaneous coronary intervention (pPCI) between 2017 and 2022. All participants were divided into 2 groups according to their NPS. The relationship between these 2 groups and LVEF was evaluated. The low-Naples risk group (Group-1) included 799 patients, and the high-Naples risk group (Group-2) had 1481 patients. Hospital mortality, shock, and no-reflow rates were found to be higher in Group 2 compared with Group 1 (

Identifiants

pubmed: 36863021
doi: 10.1177/00033197231161903
doi:

Types de publication

Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

36-43

Déclaration de conflit d'intérêts

Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Auteurs

Oğuzhan Birdal (O)

Department of Cardiology, Atatürk University, Erzurum, Turkey.

Levent Pay (L)

Department of Cardiology, Ardahan State Hospital, Sugoze, Turkey.

Emrah Aksakal (E)

Department of Cardiology, Erzurum City Hospital, Erzurum, Turkey.

Ahmet Çağdaş Yumurtaş (AÇ)

Department of Cardiology, Dr Siyami Ersek Thoracic and Cardiovascular Surgery Training Hospital, Istanbul, Turkey.

Göksel Çinier (G)

Department of Cardiology, Başakşehir Çam ve Sakura City Hospital, Istanbul, Turkey.

Enver Yücel (E)

Department of Cardiology, Kosuyolu Heart Research and Training Hospital, Istanbul, Turkey.

İbrahim Halil Tanboğa (İH)

Department of Cardiology and Biostatistics, Nisantasi University, Istanbul, Turkey.

Ali Karagöz (A)

Department of Cardiology, Kosuyolu Heart Research and Training Hospital, Istanbul, Turkey.

Vecih Oduncu (V)

Department of Cardiology, Bahcesehir University, Istanbul, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH